JMB-HEADER RAS-JOURNALS EIMB Pleiades Publishing

RUS

             

ENG

YearIMPACT-FACTOR
2022  1,200
2021  1,540
2020  1,374
2019  1,023
2018  0,932
2017  0,977
2016  0,799
2015  0,662
2014  0,740
2013  0,739
2012  0,637
2011  0,658
2010  0,654
2009  0,570
2008  0,849
2007  0,805
2006  0,330
2005  0,435
2004  0,623
2003  0,567
2002  0,641
2001  0,490
2000  0,477
1999  0,762
1998  0,785
1997  0,507
1996  0,518
1995  0,502
Vol 47(2013) N 3 p. 419-428;
D.V. Glazkova1*, A.S. Vetchinova1, E.V. Bogoslovskaya1**, Y.A. Zhogina1, M.L. Markelov2, G.A. Shipulin1

Downregulation of Human CCR5 Gene Expression with Artificial microRNAs

1Central Research Institute for Epidemiology, Moscow, 111123 Russia
2Institute of Occupational Health, Russian Academy of Medical Sciences, Moscow, 105275 Russia
Received - 2012-11-21; Accepted - 2012-12-27

Chemokine receptor 5 (CCR5) is one of the two coreceptors that are utilized by the human immu nodeficiency virus (HIV) to enter the cell. CCR5 inactivation is considered to be a promising approach to HIV therapy, including gene therapy. RNA interference provides a powerful tool to regulate gene expression and may be utilized to knockdown the CCR5 gene. Three artificial microRNAs (amiRNAs) directed to the human CCR5 gene were constructed, and their silencing activity was tested in indicator cells, which were derived from the HT1080 human cell line. A multiplexing of two or more amiRNAs in one transcript was shown to enhance the CCR5 gene silencing. A 95% reduction of CCR5 expression was achieved with the most efficient amiRNA combination.

human CCR5, microRNA, RNA interference, HIV infection, lentiviral vectors, HT1080, indicator cells



JMB-FOOTER RAS-JOURNALS